Skip to main content
. 2021 Nov 17;14:162. doi: 10.1186/s13048-021-00907-9

Fig. 7.

Fig. 7

Ghrelin specifically inhibited HO-8910 PM. A-B MTT assay of A2780S (A) and A2780CP (B) under ghrelin treatment (10 nM) in the presence or absence of cisplatin (1 μg/ml). C-D The BrdU incorporation by HUVEC (C), Gist-T1 and iPSC-MSC (D) under the treatment of ghrelin. E A schematic showing the effects of ghrelin sensitizing HO-8910 PM to cisplatin. * p < 0.05, ***p < 0.001